Fusion Pharmaceuticals Inc. Accrued Liabilities, Current
Fusion Pharmaceuticals Inc. had Accrued Liabilities, Current of $10.26 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-08
- 2022-09-30: Accrued Liabilities, Current $10.26M.
- 2022-06-30: Accrued Liabilities, Current $7.88M.
- 2022-03-31: Accrued Liabilities, Current $7.87M.
- 2021-12-31: Accrued Liabilities, Current $7.56M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-09-30 | $10.26M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.88M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.87M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $7.56M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $6.15M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.68M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $4.19M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $4.66M 10-K · filed 2022-03-17 |
| 2020-09-30 | $4.35M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $6.63M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $3.33M 10-K · filed 2021-03-25 |